The specialty chemicals franchise posts best-in-class margins and superior peer-group returns supported by a positive news backdrop, but the stock sits below its long-term moving average, carries a premium multiple well above the market, and a favorable reward-to-risk direction does not yet clear the minimum asymmetry threshold — a setup that warrants patience rather than urgency.
Thesis pillars
- Premium Valuation Limits Upside↓Deteriorating
- Best In Class Quality Versus Peers↑Improving
- Death Cross Technical Headwind↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 23, 2026· older than 90 days
Ecolab Inc. (ECL) Stock Analysis
Basic Materials · Specialty Chemicals
Sell if holding. Analyst target reached at $315.01 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.2% away).
Ecolab provides water treatment, hygiene, and infection prevention products and services across four segments — Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences — in over 170 countries. With $16 billion in annual sales and 48,000... Read more
Sell if holding. Analyst target reached at $315.01 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.2% away). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.3/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 96d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
About Ecolab Inc.
About Ecolab Inc.
Ecolab generated $16 billion in annual sales in 2025 across four segments serving customers in more than 170 countries and 40 industries: Global Water supplies treatment programs to industrial manufacturers, food processors, refineries, and power generators; Global Institutional & Specialty covers warewashing, infection prevention, and QSR cleaning programs; Global Pest Elimination serves commercial food and hospitality segments; and Global Life Sciences supplies pharmaceutical and biopharma purification. The company employs 48,000 associates, with 43% in North America.
The company earns revenue primarily from product and equipment sales recognized at point of sale, and from pest elimination services recognized as delivered. Warewashing products — sold under the "Ecolab" and "Kay" brands to QSR chains, food retailers, and hospitality customers — accounted for approximately 13% of consolidated net sales in 2025. The Global Water segment competes against a few large global chemical companies alongside smaller regional players, with pricing tied to demonstrable reductions in customer water and energy consumption. The Life Sciences segment, which includes Purolite biopharma resin products and Bioquell decontamination systems, competes against mid-size and regional rivals in Europe and North America. Approximately 47% of net sales originate from outside the United States, and international profitability is generally lower due to regulatory diversity, reliance on third-party distributors in certain markets, and smaller operational scale in many regions.
Show full overview
Raw material price volatility may impact Ecolab materially — the 10-K notes that changes in raw material prices or unavailability of adequate and reasonably priced substitutes has materially and adversely affected the business in the past. Tariffs imposed on a broad range of imported goods during 2025 may increase procurement costs beyond what current rate structures reflect. Separately, the company is implementing ERP system upgrades expected to continue in phases over several years and a "One Ecolab" restructuring initiative that realigns country operations into global centers of excellence; failure of either program could affect operating efficiency and cash flows.
See also: Basic Materials · Specialty Chemicals
From Ecolab Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated Nov 3, 2026Recent Developments — Ecolab Inc.
Latest news
- NEWS Here’s How Much You Would Have Made Owning Ecolab Stock In The Last 20 Years — benzinga Nov 3, 2026 positive
- NEWS Ecolab (ECL) Q3 Earnings Showcase Margin Strength Despite EPS Drag - Yahoo Finance — Yahoo Finance Oct 28, 2026 neutral
- NEWS Why Ecolab (ECL) Is Getting Attention Today - Simply Wall Street — Simply Wall Street Oct 27, 2026 neutral
- NEWS Ecolab Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:ECL) 2026-10-27 - Seeking Alpha — Seeking Alpha Oct 27, 2026 neutral
- NEWS Ecolab Q3 2026 Earnings Call Transcript - Benzinga — Benzinga Oct 27, 2026 neutral
Latest item Nov 3, 2026 · Generated 2026-11-05T11:54:11Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWProductwarewashing products13%10-K Item 1: 'Sales of warewashing products were approximately 13% of consolidated net sales in 2025'
- MEDIUMCustomerlimited number of major QSR chains10-K Item 1: 'Specialty's business remains largely dependent upon a limited number of major QSR chains and franchisees and large food retail customers'
Material Events(8-K, last 90d)
- 2026-05-11Item 5.02LOWBryce L. Mewhorter elected SVP and Corporate Controller (principal accounting officer), effective after Q2 2026 10-Q filing. Jennifer J. Bradway remains at company in a different role. Clean internal succession, no departure.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $315.01 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (0.2% away). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $301.67. Score 5.3/10, moderate confidence.
Analyst target $297.51 reached (−5.6% from $315.01); no take-profit level is published. Prior stop was $301.67. Stop-loss: $301.67.
Analyst target reached - limited upside remaining; Near 52-week high (0.2% away); Sector modifier (Basic Materials): -0.1.
Ecolab Inc. trades at a P/E of 42.9 (forward 33.5). TrendMatrix value score: 3.6/10. Verdict: Sell.
30 analysts rate ECL, with a consensus score of 4.1/5. 21 analysts publish price targets averaging $331.
What does Ecolab Inc. do?Ecolab provides water treatment, hygiene, and infection prevention products and services across four segments — Global...
Ecolab provides water treatment, hygiene, and infection prevention products and services across four segments — Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences — in over 170 countries. With $16 billion in annual sales and 48,000 employees, Ecolab sells primarily to industrial, foodservice, hospitality, and pharmaceutical customers through direct field sales.